Zusammenfassung
Obwohl das mesolimbische dopaminerge System als die zentrale Suchtregion im Gehirn identifiziert wurde, zeigt sich die wissenschaftliche Befundlage zu den spezifischen neurobehavioralen Korrelaten des Drogenkonsums immer noch sehr lückenhaft. Die bisher vorliegenden Studienergebnisse geben daher nur orientierende Hinweise. Noch weitgehend unerforscht sind Aspekte der Hirnreifung und psychosozialen Entwicklung bei Langzeitkonsum unterschiedlicher Drogen, insbesondere was die Wechselwirkung zwischen genetischer Suszeptibilität und Konsumbeginn in vulnerablen Entwicklungsphasen betrifft. Bei Betrachtung der wissenschaftlichen Datenlage wird aber auch deutlich, wie schwierig Untersuchungen zu diesen Themenkomplexen sind, da eine Vielzahl von Faktoren Einfluss auf die Untersuchungsergebnisse nehmen kann.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Andréasson S, Allebeck P, Engstrom A, Rydberg U (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2:1483–1486
Baker D, Pryce G, Giovannoni G, Thompson AJ (2003) The therapeutic potential of cannabis. Lancet Neurol 2:291–297
Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P (2000) Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Research: Neuroimaging 98:93–102
Block RI, O'Leary DS, Hichwa RD, Augustinack JC, Boles Ponto LL, Ghoneim MM, Arndt S, Hurtig RR, Watkins GL, Hall JA, Nathan PE, Andreasen NC (2002) Effects of frequent marijuanause on memory-related regional cerebral bloodflow. Pharmacol Biochem Behavior 72:237–250
Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington HL, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry 57:1117–1127
Chambers RA, Taylor JR, Potenza MN (2003) Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160:1041–1052
Copeland J, Swift W, Rees V (2001): Clinical profileofparticipants in a brief intervention program for cannabisusedisorder. J Subst Abuse Treat 20, 45–52
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949
Fergusson DM, Poulton R, Smith PF, Boden JM (2006) Cannabis andpsychosis. BMJ 332:172–175
Fernandez-Ruiz J, Berrendero F, Hernandez ML, Ramos JA (2000) The endogeneous cannabinoid system and brain development. Trends Neurosci 23:14–20
Fried P (1996) Behavioural outcomes in preschool and schoolage children exposed prenatally to marijuana: a review and speculative interpretation. In: Wetherington CL, Smerigloio VL, Finnegan LP (Hrsg) Behavioral studies of drug exposed offspring: methodological issues in human and animal research. NIDA Res Monogr 164, U. S. Government Printing Office, Washington DC, S 242–260
Gianaros PJ, Manuck SB (2010) Neurobiological pathways linking socioeconomic position and health. Psychosom- Med 72:450–461
Gillespie NA, Kendler KS, Prescott CA, Aggen SH, Gardner CO JR, Jacobson K, Neale MC (2007) Longitudinal modelingofgeneticand environmental influences on selfreported availability of psychoactive substances: alcohol, cigarettes, marijuana, cocaineandstimulants. Psychol Med 37:947–959
Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1652
Huestegge L, Radach R, Kunert HJ, Heller D (2002) Visual search in long term cannabis users with early age of onset. Prog Brain Res 140:377–394
Jacobsen LK, Pugh KR, Constable RT, Westerveld M, Mencl WE (2007) Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol Psychiatry 61:31–40
Kunert HJ, Kempel P, Lampe K, Parnefjord R, Moeller MR (2000) Ereigniskorrelierte Potentialveränderungen bei chronischem Cannabiskonsum mit frühem »Age of Onset«. Nervenarzt 71:33
Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002) Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51:890–895
Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabonoid system controls extinction of aversive memories. Nature 418:530–534
Musso F, Bettermann F, Vucurevic G, Stoeter P, Konrad A, Winterer G (2007) Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology 191:159–169
Navarro M, Fernandez-Ruiz JJ, de Miguel R, Hernandez ML, Cebeira M, Ramos JA (1993) An acute dose of delta-9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav Brain Res 57:37–47
O'Brien CP (2009) Neuroplasticity in addictive disorders. Dialogues Clin Neurosci 11:350–353
Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, Robbins TW (2000) Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23:113–126
Os J van, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H (2002) Cannabis use and psychosis: longitudinal population based study. Am J Epidemiol 156:319–327
Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W (2002) Cannabis use and mental health in young people: cohort study. BMJ 325:1195–1198
Pertwee RG (1992) In vivo interactions between psychotropic cannabinoids and other drugs involving central and peripheral neurochemical mechanisms. In: Murphy L, Bartke A (Hrsg) Marijuana/Cannabinoids: Neurobiology and Neurophysiology. CRC Press, BocaRaton, S 165–218
Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2001) Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58:909–915
Rey JM, Sawyer MG, Raphael B, Patton GC, Lynskey M (2002) Mental health teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry 180:216–221
Ross S, Peselow E (2009) The neurobiology of addictive disorders. Clin Neuropharmacol 32:269–276
Schneider U, Müller-Vahl KR, Stuhrmann M, Gadzicki D, Heller D, Seifert JN, Emrich HM (2000) Die Bedeutung des endogenen Cannabinoidsystems bei verschiedenen neuropsychiatrischen Erkrankungen. Fortschr Neurol Psychiat 68:433–438
SolaLlopis de S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R (2008) Cognitive performance in recreational ecstasy polydrugusers: a two-yearfollow-upstudy. J Psychopharmacol 22(5):498– 510
Solinas M, Chauvet C, Thiriet N, El Rawas R, Jaber M (2008) Reversal of cocaine addiction by environmental enrichment. PNAS 105:17145–17150
Solowij N (1998) Cannabis and cognitive functioning. University Press, Cambridge
Solowij N, Michie PT, Fox AM (1995) Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37:731–739
Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287:1123–1131
Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, van Os J (2004) Early adolescent cannabis exposure and positive and negative dimensions on psychosis. Addiction 99:1333–1341
Sundram S (2006) Cannabis and neurodevelopment: implications for psychiatric disorders. Hum Psychopharmacol 21:245–254
Wessels C, Winterer G (2008) Nikotin und Gehirnentwicklung. Nervenarzt 79:7–16
Yacubian J, Buchel C (2009) The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. Neuroscience 164:55–71
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kunert, H.J. (2012). Neurowissenschaftliche Befunde bei Drogenkonsum. In: Schneider, F. (eds) Positionen der Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25476-5_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-25476-5_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25475-8
Online ISBN: 978-3-642-25476-5
eBook Packages: Medicine (German Language)